Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Achieve Life Sciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +4 vs. Q4 2021
- Shares held
- 1.93M
- +13.5K (+0.7%) vs. Q4 2021
- Total value
- $14.6M
- −$296.0K (−2.0%) vs. Q4 2021
- New holders
- 6
- 7 more added
- Sold out
- 2
- 8 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $538.7M |
| Q1 2026 | 81 | $63.6M |
| Q4 2025 | 77 | $115.3M |
| Q3 2025 | 66 | $48.9M |
| Q2 2025 | 66 | $59.3M |
| Q1 2025 | 72 | $38.4M |
| Q4 2024 | 70 | $57.5M |
| Q3 2024 | 64 | $81.2M |
| Q2 2024 | 56 | $78.4M |
| Q1 2024 | 41 | $64.9M |
| Q4 2023 | 29 | $11.2M |
| Q3 2023 | 35 | $13.4M |
| Q2 2023 | 39 | $18.6M |
| Q1 2023 | 31 | $16.6M |
| Q4 2022 | 28 | $4.90M |
| Q3 2022 | 28 | $7.00M |
| Q2 2022 | 31 | $9.97M |
| Q1 2022 | 33 | $14.6M |
| Q4 2021 | 29 | $14.9M |
| Q3 2021 | 32 | $15.2M |
| Q2 2021 | 29 | $17.5M |
| Q1 2021 | 16 | $11.7M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Achieve Life Sciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Newbridge Financial Services Group, Inc. | 308 | $2.00K | 0.00% | 00.0% | Unchanged |
| Godsey & Gibb Associates | 453 | $3.00K | 0.00% | +453 | New |
| Tower Research Capital LLC (TRC) | 1,158 | $9.00K | 0.00% | +1,058+1,058.0% | Added |
| Advisor Group Holdings, Inc. | 1,643 | $12.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,755 | $13.0K | 0.00% | +1,755 | New |
| Wells Fargo & Company | 5,593 | $42.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 6,449 | $49.0K | 0.00% | −48,557−88.3% | Reduced |
| Schonfeld Strategic Advisors LLC | 10,200 | $77.0K | 0.00% | +10,200 | New |
| Charles Schwab Investment Management Inc | 10,306 | $79.0K | 0.00% | +10,306 | New |
| Occudo Quantitative Strategies LP | 11,001 | $83.0K | 0.01% | 00.0% | Unchanged |
| Paradigm Financial Partners, LLC | 11,750 | $92.0K | 0.02% | 00.0% | Unchanged |
| Simplex Trading, LLC | 12,486 | $94.0K | 0.00% | +12,145+3,561.6% | Added |
| Two Sigma Advisers, LP | 12,485 | $95.0K | 0.00% | −4,770−27.6% | Reduced |
| Raymond James & Associates | 13,114 | $99.0K | 0.00% | +13,114 | New |
| BlackRock Inc. | 15,207 | $115.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,099 | $129.0K | 0.00% | +85+0.5% | Added |
| Pura Vida Investments, LLC | 17,325 | $131.0K | 0.02% | +1,000+6.1% | Added |
| State Street Corp | 18,731 | $142.0K | 0.00% | +3,970+26.9% | Added |
| Oppenheimer & Co Inc | 22,300 | $169.0K | 0.00% | −2,500−10.1% | Reduced |
| Renaissance Technologies LLC | 25,200 | $191.0K | 0.00% | +1,400+5.9% | Added |
| Franklin Resources Inc | 33,967 | $257.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 40,400 | $306.0K | 0.00% | −1,000−2.4% | Reduced |
| DLD Asset Management, LP | 45,528 | $345.0K | 0.02% | +45,528 | New |
| Long Focus Capital Management, LLC | 60,000 | $454.0K | 0.10% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 80,444 | $609.0K | 0.00% | −19,858−19.8% | Reduced |
| Geode Capital Management, LLC | 85,554 | $647.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 86,550 | $655.0K | 0.00% | +17,600+25.5% | Added |
| Clearline Capital LP | 120,094 | $909.0K | 0.12% | −1,918−1.6% | Reduced |
| Altium Capital Management LP | 122,000 | $924.0K | 0.32% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 125,000 | $946.0K | 0.06% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 174,600 | $1.32M | 1.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 342,905 | $2.60M | 0.00% | −2,870−0.8% | Reduced |
| Shay Capital LLC | 401,368 | $3.04M | 1.09% | −4,349−1.1% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,207−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −80−100.0% | Sold out |